PERSPECTA

News from every angle

Back to headlines

Alector Stock Plummets as GSK Terminates Neuroscience Pact

Alector's stock dropped by 13% following the termination of its neuroscience partnership with GSK.

9 Jul, 04:23 — 9 Jul, 04:23
PostShare

Sources

Showing 1 of 1 sources